| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ADA
|
adenosine deaminase
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADK
|
adenosine kinase
|
|
ADORA1
|
adenosine A1 receptor
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADORA2B
|
adenosine A2b receptor
|
|
ADORA3
|
adenosine A3 receptor
|
|
ADRA1A
|
adrenoceptor alpha 1A
|
|
ADRA1D
|
adrenoceptor alpha 1D
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRA2B
|
adrenoceptor alpha 2B
|
|
ADRA2C
|
adrenoceptor alpha 2C
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AKR1A1
|
aldo-keto reductase family 1, member A1 (aldehyde reductase)
|
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase)
|
|
AKR1B10
|
aldo-keto reductase family 1, member B10 (aldose reductase)
|
|
AKR1C1
|
aldo-keto reductase family 1, member C1
|
|
AKR1C2
|
aldo-keto reductase family 1, member C2
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKR1C4
|
aldo-keto reductase family 1, member C4
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALOX12
|
arachidonate 12-lipoxygenase
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ALOX5AP
|
arachidonate 5-lipoxygenase-activating protein
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
AMPD3
|
adenosine monophosphate deaminase 3
|
|
AMY1A
|
amylase, alpha 1A (salivary)
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
APH1A
|
APH1A gamma secretase subunit
|
|
APH1B
|
APH1B gamma secretase subunit
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
ARG1
|
arginase 1
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
AVPR1A
|
arginine vasopressin receptor 1A
|
|
AVPR2
|
arginine vasopressin receptor 2
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BMX
|
BMX non-receptor tyrosine kinase
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
CA1
|
carbonic anhydrase I
|
|
CA12
|
carbonic anhydrase XII
|
|
CA13
|
carbonic anhydrase XIII
|
|
CA14
|
carbonic anhydrase XIV
|
|
CA2
|
carbonic anhydrase II
|
|
CA3
|
carbonic anhydrase III
|
|
CA4
|
carbonic anhydrase IV
|
|
CA5A
|
carbonic anhydrase VA, mitochondrial
|
|
CA6
|
carbonic anhydrase VI
|
|
CA7
|
carbonic anhydrase VII
|
|
CA9
|
carbonic anhydrase IX
|
|
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit
|
|
CACNA2D1
|
calcium channel, voltage-dependent, alpha 2/delta subunit 1
|
|
CACNA2D2
|
calcium channel, voltage-dependent, alpha 2/delta subunit 2
|
|
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta
|
|
CCNA1
|
cyclin A1
|
|
CCNA2
|
cyclin A2
|
|
CCNB1
|
cyclin B1
|
|
CCNB2
|
cyclin B2
|
|
CCNB3
|
cyclin B3
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCND3
|
cyclin D3
|
|
CCNE1
|
cyclin E1
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
|
CD38
|
CD38 molecule
|
|
CDC25A
|
cell division cycle 25A
|
|
CDC25B
|
cell division cycle 25B
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK3
|
cyclin-dependent kinase 3
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35)
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDK8
|
cyclin-dependent kinase 8
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CES2
|
carboxylesterase 2
|
|
CFD
|
complement factor D (adipsin)
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHRM1
|
cholinergic receptor, muscarinic 1
|
|
CHRM2
|
cholinergic receptor, muscarinic 2
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CLK1
|
CDC-like kinase 1
|
|
CLK2
|
CDC-like kinase 2
|
|
CLK4
|
CDC-like kinase 4
|
|
CMA1
|
chymase 1, mast cell
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSNK1D
|
casein kinase 1, delta
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CTSB
|
cathepsin B
|
|
CTSD
|
cathepsin D
|
|
CTSL
|
cathepsin L
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CYP11B1
|
cytochrome P450, family 11, subfamily B, polypeptide 1
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP51A1
|
cytochrome P450, family 51, subfamily A, polypeptide 1
|
|
CYSLTR1
|
cysteinyl leukotriene receptor 1
|
|
DAO
|
D-amino-acid oxidase
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DCTPP1
|
dCTP pyrophosphatase 1
|
|
DGAT1
|
diacylglycerol O-acyltransferase 1
|
|
DHFR
|
dihydrofolate reductase
|
|
DNM1
|
dynamin 1
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
DRD3
|
dopamine receptor D3
|
|
DRD4
|
dopamine receptor D4
|
|
DUSP3
|
dual specificity phosphatase 3
|
|
DYRK1A
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A
|
|
DYRK1B
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B
|
|
EGFR
|
epidermal growth factor receptor
|
|
ELANE
|
elastase, neutrophil expressed
|
|
EPHA2
|
EPH receptor A2
|
|
EPHX2
|
epoxide hydrolase 2, cytoplasmic
|
|
ERN1
|
endoplasmic reticulum to nucleus signaling 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRRA
|
estrogen-related receptor alpha
|
|
ESRRB
|
estrogen-related receptor beta
|
|
F10
|
coagulation factor X
|
|
F2
|
coagulation factor II (thrombin)
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FASN
|
fatty acid synthase
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FGR
|
FGR proto-oncogene, Src family tyrosine kinase
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FNTA
|
farnesyltransferase, CAAX box, alpha
|
|
FNTB
|
farnesyltransferase, CAAX box, beta
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOXO1
|
forkhead box O1
|
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1
|
|
GABRA3
|
gamma-aminobutyric acid (GABA) A receptor, alpha 3
|
|
GABRA5
|
gamma-aminobutyric acid (GABA) A receptor, alpha 5
|
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3
|
|
GABRG2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
GBA1
|
glucosylceramidase beta 1
|
|
GBA2
|
glucosidase, beta (bile acid) 2
|
|
GCGR
|
glucagon receptor
|
|
GLO1
|
glyoxalase I
|
|
GPR35
|
G protein-coupled receptor 35
|
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2
|
|
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1
|
|
GRIN2A
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A
|
|
GRK1
|
G protein-coupled receptor kinase 1
|
|
GRK2
|
G protein-coupled receptor kinase 2
|
|
GRK6
|
G protein-coupled receptor kinase 6
|
|
GRM1
|
glutamate receptor, metabotropic 1
|
|
GRM2
|
glutamate receptor, metabotropic 2
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC6
|
histone deacetylase 6
|
|
HDAC8
|
histone deacetylase 8
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HK1
|
hexokinase 1
|
|
HK2
|
hexokinase 2
|
|
HPSE
|
heparanase
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSD17B14
|
hydroxysteroid (17-beta) dehydrogenase 14
|
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
|
HSD3B2
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
|
HSPA8
|
heat shock 70kDa protein 8
|
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTR2B
|
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
HTR6
|
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon
|
|
IL2
|
interleukin 2
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
INSR
|
insulin receptor
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
KCNA3
|
potassium channel, voltage gated shaker related subfamily A, member 3
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KDR
|
kinase insert domain receptor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS4
|
lectin, galactoside-binding, soluble, 4
|
|
LGALS8
|
lectin, galactoside-binding, soluble, 8
|
|
LNPEP
|
leucyl/cystinyl aminopeptidase
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LSS
|
lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase)
|
|
LTB4R
|
leukotriene B4 receptor
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAOA
|
monoamine oxidase A
|
|
MAOB
|
monoamine oxidase B
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP4K2
|
mitogen-activated protein kinase kinase kinase kinase 2
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK11
|
mitogen-activated protein kinase 11
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAPT
|
microtubule-associated protein tau
|
|
MCHR1
|
melanin-concentrating hormone receptor 1
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MERTK
|
MER proto-oncogene, tyrosine kinase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPG
|
N-methylpurine-DNA glycosylase
|
|
MPO
|
myeloperoxidase
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MTNR1A
|
melatonin receptor 1A
|
|
MTNR1B
|
melatonin receptor 1B
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYLK
|
myosin light chain kinase
|
|
NCSTN
|
nicastrin
|
|
NEK1
|
NIMA-related kinase 1
|
|
NEK2
|
NIMA-related kinase 2
|
|
NEK6
|
NIMA-related kinase 6
|
|
NMUR2
|
neuromedin U receptor 2
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOX4
|
NADPH oxidase 4
|
|
NQO2
|
NAD(P)H dehydrogenase, quinone 2
|
|
NR1H2
|
nuclear receptor subfamily 1, group H, member 2
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
|
NUAK1
|
NUAK family, SNF1-like kinase, 1
|
|
OGA
|
O-GlcNAcase
|
|
OPRD1
|
opioid receptor, delta 1
|
|
OPRK1
|
opioid receptor, kappa 1
|
|
OPRL1
|
opiate receptor-like 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OXTR
|
oxytocin receptor
|
|
P2RX3
|
purinergic receptor P2X, ligand gated ion channel, 3
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PDE10A
|
phosphodiesterase 10A
|
|
PDE2A
|
phosphodiesterase 2A, cGMP-stimulated
|
|
PDE3A
|
phosphodiesterase 3A, cGMP-inhibited
|
|
PDE3B
|
phosphodiesterase 3B, cGMP-inhibited
|
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific
|
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDK1
|
pyruvate dehydrogenase kinase, isozyme 1
|
|
PFKFB3
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
|
|
PGGT1B
|
protein geranylgeranyltransferase type I, beta subunit
|
|
PGR
|
progesterone receptor
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PITRM1
|
pitrilysin metallopeptidase 1
|
|
PKN1
|
protein kinase N1
|
|
PLA2G1B
|
phospholipase A2, group IB (pancreas)
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLK1
|
polo-like kinase 1
|
|
PNMT
|
phenylethanolamine N-methyltransferase
|
|
POLB
|
polymerase (DNA directed), beta
|
|
PRCP
|
prolylcarboxypeptidase (angiotensinase C)
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCH
|
protein kinase C, eta
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PSEN1
|
presenilin 1
|
|
PSEN2
|
presenilin 2
|
|
PSENEN
|
presenilin enhancer gamma secretase subunit
|
|
PTAFR
|
platelet-activating factor receptor
|
|
PTGER1
|
prostaglandin E receptor 1 (subtype EP1), 42kDa
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN2
|
protein tyrosine phosphatase, non-receptor type 2
|
|
PTPRS
|
protein tyrosine phosphatase, receptor type, S
|
|
PYGL
|
phosphorylase, glycogen, liver
|
|
RASGRP3
|
RAS guanyl releasing protein 3 (calcium and DAG-regulated)
|
|
REN
|
renin
|
|
RET
|
ret proto-oncogene
|
|
RIPK2
|
receptor-interacting serine-threonine kinase 2
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
ROCK2
|
Rho-associated, coiled-coil containing protein kinase 2
|
|
RORA
|
RAR-related orphan receptor A
|
|
RORC
|
RAR-related orphan receptor C
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
S1PR3
|
sphingosine-1-phosphate receptor 3
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SERPINA6
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHH
|
sonic hedgehog
|
|
SIGMAR1
|
sigma non-opioid intracellular receptor 1
|
|
SLC10A1
|
solute carrier family 10 (sodium/bile acid cotransporter), member 1
|
|
SLC10A2
|
solute carrier family 10 (sodium/bile acid cotransporter), member 2
|
|
SLC22A12
|
solute carrier family 22 (organic anion/urate transporter), member 12
|
|
SLC28A2
|
solute carrier family 28 (concentrative nucleoside transporter), member 2
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SLC5A1
|
solute carrier family 5 (sodium/glucose cotransporter), member 1
|
|
SLC5A2
|
solute carrier family 5 (sodium/glucose cotransporter), member 2
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC6A9
|
solute carrier family 6 (neurotransmitter transporter, glycine), member 9
|
|
SMO
|
smoothened, frizzled class receptor
|
|
SOAT1
|
sterol O-acyltransferase 1
|
|
SOAT2
|
sterol O-acyltransferase 2
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRD5A1
|
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
SYK
|
spleen tyrosine kinase
|
|
TACR1
|
tachykinin receptor 1
|
|
TACR2
|
tachykinin receptor 2
|
|
TAOK1
|
TAO kinase 1
|
|
TAOK3
|
TAO kinase 3
|
|
TAS2R31
|
taste receptor, type 2, member 31
|
|
TBK1
|
TANK-binding kinase 1
|
|
TBXAS1
|
thromboxane A synthase 1 (platelet)
|
|
TERT
|
telomerase reverse transcriptase
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TIE1
|
tyrosine kinase with immunoglobulin-like and EGF-like domains 1
|
|
TLR9
|
toll-like receptor 9
|
|
TNF
|
tumor necrosis factor
|
|
TNKS
|
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase
|
|
TNKS2
|
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 2
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TTR
|
transthyretin
|
|
TYMP
|
thymidine phosphorylase
|
|
TYMS
|
thymidylate synthetase
|
|
TYR
|
tyrosinase
|
|
TYRO3
|
TYRO3 protein tyrosine kinase
|
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7
|
|
UPP1
|
uridine phosphorylase 1
|
|
VCP
|
valosin containing protein
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
|
XDH
|
xanthine dehydrogenase
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
